Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers

Rebouissou et al. recently provided preclinical evidence that a subset of patients with muscle-invasive bladder cancer might benefit from anti-epidermal growth factor receptor (EGFR) therapy and reported diagnostic tools for identifying these patients in the clinical setting. This work also identifi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Cell Oncol
Main Authors: Lebret, Thierry, Neuzillet, Yann, Houede, Nadine, Rebouissou, Sandra, Bernard-Pierrot, Isabelle, De Reynies, Aurélien, Benhamou, Simone, Allory, Yves, Radvanyi, François
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Author's View
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905367/
https://ncbi.nlm.nih.gov/pubmed/27308521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2014.999507
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki